These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5917630)

  • 1. Further trials with Astiban in schistosomiasis mansoni: the effect of increased dosage.
    Zaki MH; De Ramos S; Shookhoff HB; Sterman M
    Am J Trop Med Hyg; 1966 Sep; 15(5):725-9. PubMed ID: 5917630
    [No Abstract]   [Full Text] [Related]  

  • 2. Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.
    Farid Z; Bassily S; McConnell E; Davis J
    Ann Trop Med Parasitol; 1967 Sep; 61(3):310-4. PubMed ID: 5625700
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial of Astiban in treating university students in the Sudan.
    Hamad B
    J Trop Med Hyg; 1969 Sep; 72(9):229-30. PubMed ID: 4899483
    [No Abstract]   [Full Text] [Related]  

  • 4. Microencapsulation of astiban acid for the treatment of Schistosomiasis mansoni.
    Gopalratnam PC; Mason NS; Sparks RE
    Appl Biochem Biotechnol; 1984; 10():213-20. PubMed ID: 6098224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the serial oogram in determining the therapeutic effectiveness of TWSB-6 (Astiban-6) in schistosomiasis mansoni].
    Tonelli E; Neves J
    Hospital (Rio J); 1965 Aug; 68(2):353-69. PubMed ID: 5295126
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of frequency of administration on antimony activity against Schistosoma mansoni in mice.
    DeWitt WB
    Am J Trop Med Hyg; 1965 Nov; 14(6):1003-6. PubMed ID: 5840635
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral tracer sodium antimony-2, 3-meso-dimercapto-succinate (Astiban) in hamsters infected with Schistosoma mansoni.
    Girgis GR; Girgis NI; Schulert AR; McConnell E
    J Egypt Public Health Assoc; 1966; 41(4):237-42. PubMed ID: 6002838
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Oral dosing of antimonials against Schistosoma mansoni.
    Coles GC
    Trans R Soc Trop Med Hyg; 1975; 69(2):291. PubMed ID: 1166501
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parameters in the experimental chemotherapy of schistosomiasis 9s. mansoni)].
    Ercoli N; Payares G
    Acta Cient Venez; 1969; 20(5):164-7. PubMed ID: 5382955
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative antimony disposition following administration of tartar emetic and sodium antimony dimercaptosuccinate (Astiban) to hamsters infected with Schistosoma mansoni.
    Schulert AR; Girgis NI; Girgis GR; Farid Z; McConnell E
    East Afr Med J; 1967 Jan; 44(1):1-8. PubMed ID: 6038793
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of multiple doses of antimonials in Schistosoma mansoni infection.
    Khayyal MT
    Bull World Health Organ; 1965; 33(4):547-51. PubMed ID: 5294999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic use of dimercaptosuccinate of antimony and sodium (Astiban) in the treatment of Manson's schistosomiasis].
    Teixeira D; de Gouveia OF; Miyahira AR; Galper E; da Cunha MA
    Hospital (Rio J); 1965 Dec; 68(6):1361-75. PubMed ID: 5295283
    [No Abstract]   [Full Text] [Related]  

  • 13. ASTIBAN IN SCHISTOSOMIASIS MANSONI: A CONTROLLED THERAPEUTIC TRIAL IN A NONENDEMIC AREA.
    ZAKI MH; SHOOKHOFF HB; STERMAN M; DERAMOS S
    Am J Trop Med Hyg; 1964 Nov; 13():803-10. PubMed ID: 14222433
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppressive therapy with MsbE and Astiban in hamsters infected with Schistosoma mansoni.
    Baldewsing R
    Trop Geogr Med; 1973 Jun; 25(2):174-8. PubMed ID: 4736841
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative trials of antimonial drugs in urinary schistosomiasis.
    Davis A
    Bull World Health Organ; 1968; 38(2):197-227. PubMed ID: 5302298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and clinical studies with a new antimonial preparation for the treatment of schistosomiasis.
    Pedrique MR; Ercoli N
    Bull World Health Organ; 1971; 45(4):411-7. PubMed ID: 5317079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of schistosomiasis of the urinary bladder with astiban].
    Aslamazov AG
    Med Parazitol (Mosk); 1975; 44(2):160-5. PubMed ID: 1214716
    [No Abstract]   [Full Text] [Related]  

  • 18. A 13-year follow-up of antimony-treated Schistosoma mansoni-infected patients.
    Hedman P; Bengtsson E
    Am J Trop Med Hyg; 1977 Jul; 26(4):693-5. PubMed ID: 889011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of subtherapeutic doses of antimony therapy in experimental hepatic mansoniasis.
    Habib A; Wassef SA; Ata AA
    J Egypt Med Assoc; 1970; 53(5):351-62. PubMed ID: 5506291
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary function in patients with early asymptomatic schistosomiasis before and after treatment with sodium antimony dimercaptosuccinate (Astiban).
    Fuleihan FJ; Abboud RT
    Am J Trop Med Hyg; 1968 May; 17(3):372-7. PubMed ID: 5652697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.